Seeking Alpha

Venaxis, Inc. (APPY)

  • pat45 | Send Message 22 Apr

    $APPY to start sales in Spain soon
    Reply (3)
  • View all 3 replies
    • pat45 | Send Message 22 Apr
      : APPY euro partner laboratories Rubio is finishing studies and will launch in 17 Spanish hospitals soon. In SEC Filings from event on 4/7.
    • pat45 | Send Message 22 Apr
      : They did get CE can sell in Europe
      • Daniel Ward | Send Message 21 Apr

        Why Numerous Upside Scenarios Make Venaxis A Biotech To Buy $APPY
        Reply (4)
      • View all 4 replies
        • ceristeare | Send Message 21 Apr
          : Appy1 + sonogram = no brainer. It should be standard practice over CT scan.
        • Daniel Ward | Send Message 21 Apr
          : That combo certainly does seem to have a lot of potential if they can get APPY1 through the FDA
          • Martin_Kostka | Send Message 15 Apr

            BUY $APPY 0.50 3X
              • LaboMedic | Send Message 29 Jan

                $APPY UPDATE: Canaccord Downgrades Venaxis After Significant FDA Setback
                  • pat45 | Send Message 29 Jan

                    Bot $APPY .56 it has .80 cash but .43 burn and don't know how long till test approved in USA . Has CE Mark
                    Reply (1)
                    • pat45 | Send Message 29 Jan
                      : I have been in and out of this one will hold a while now. Hope can prove equivalent soon.
                      • LaboMedic | Send Message 14 Dec 2014

                        Analyst Highlights - Week 50 - Healthcare (Part IV) $APPY $AGIO $MRK $CELG $DVAX
                          • LaboMedic | Send Message 10 Dec 2014

                            $APPY Canaccord Genuity Maintains Buy On Venaxis, Sees 184% Upside
                              • stem23 | Send Message 9 Dec 2014

                                $APPY - If FDA has no further inquiries, expect FDA announce no later then March. Company is confident of response to FDA questions
                                  • pat45 | Send Message 4 Dec 2014

                                    Bot back $APPY sales soon in Europe where it is approved and meeting with FDA soon.
                                      • Blair O'Neill | Send Message 29 Oct 2014

                                        Venaxis: Latest Clinical Data Reveals Huge Market Potential $APPY
                                          Visit Seeking Alpha's
                                          APPY vs. ETF Alternatives
                                          Company Description
                                          Venaxis Inc is engaged in the development and commercialization of products that address unmet diagnostic and therapeutic needs.